Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas-Reference-Cited by-同舟云学术

Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas

Published:2017-10 Issue: Volume:118 Page:1-6
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Vincenzi Bruno,Badalamenti Giuseppe,Napolitano Andrea,Spalato Ceruso Mariella,Pantano Francesco,Grignani Giovanni,Russo Antonio,Santini Daniele,Aglietta Massimo,Tonini Giuseppe

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference68 articles.

1. Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma: correlation with overall survival in 105 patients;Armistead;Cancer,2007

2. Adriamycin: a new effective agent in the therapy of disseminated sarcomas;Benjamin;Med. Pediatr. Oncol.,1975

3. Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas;Blay;Eur. J. Cancer,2014

4. Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma;Boonjaraspinyo;Tumour Biol.,2012

5. Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas;Borden;Cancer,1990

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An image‐based Abplex method for high‐throughput GPCRs antibody discovery;Biotechnology Journal;2023-11-20

2. Combination therapy with Olaratumab/doxorubicin in advanced or metastatic soft tissue sarcoma -a single-Centre experience;BMC Cancer;2020-01-29

3. Olaratumab combined with doxorubicin and ifosfamide overcomes individual doxorubicin and olaratumab resistance of an undifferentiated soft-tissue sarcoma in a PDOX mouse model;Cancer Letters;2019-06

4. The combination of olaratumab with gemcitabine and docetaxel arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft mouse model;Cancer Chemotherapy and Pharmacology;2019-03-30

5. PDGFRα inhibition in soft-tissue sarcomas: Have we gotten it all wrong?;EBioMedicine;2019-02